Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial ...
Developed by Johnson & Johnson, guselkumab (GUS) is the first approved fully-human, dual-acting IL-23p19 subunit inhibitor that blocks IL-23 and binds to CD64, a receptor on cells that produce IL-23.
New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...
Hosted on MSN15h
CHMP recommends AbbVie’s Rinvoq be approved for adult GCAThe treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...
Understanding gut health involves more than following diet trends. Poor gut health, linked to stress, poor diet, and ...
A West Virginia environmental group has presented evidence indicating a chemical giant is persisting in unlawfully dumping a toxic chemical into the Ohio River amid a federal court case the group ...
DHAKA: The students’ group which spearheaded the protests that led to the ouster of Sheikh Hasina as prime minister on Friday launched a political party and vowed to root out pro-India and pro ...
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback